Current clinical trial participants who are registered in the PCRU database can refer a friend or family member to screen for studies at the PCRU in New Haven, CT. Participants who make a qualified referral will be eligible to receive up to $300*.
To qualify for this referral program, referred participants:
must not have had a screening visit at the PCRU within the last 2 years
must provide the full name of the person who referred them at the time of scheduling the screening appointment or registering in the PCRU database
must complete a screening appointment and be eligible to receive the screening payment as described in the study’s informed consent document
Clinical trial participants who would like to make a referral must be registered in the PCRU database with a current mailing address and must have completed an in-person screening.
*Bonus payments will be paid in U.S. dollars. Compensation may be provided on a loadable debit card or by paper check. The New Haven PCRU reserves the right to determine method of payment. Eligibility for this program will be determined by the New Haven PCRU, and the New Haven PCRU reserves the right to change the terms or terminate this program at any time.
The Pfizer New Haven Clinical Research Unit is conducting a clinical trial of a study drug for the potential treatment of COVID-19.
The Pfizer Clinical Research Unit is seeking healthy Japanese volunteers for upcoming studies.
The Pfizer Clinical Research Unit is conducting a clinical trial of a study drug to potentially treat pulmonary arterial hypertension (PAH). You do not need to have PAH to participate.
Interested in participating?
Complete and submit this form, and a Pfizer Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.